Sponsors

Human papillomavirus vaccination

Analysis indicates that rates of high-grade cervical lesions decreased in young US women after vaccines were made available to protect against human papillomavirus (HPV), but the trend may be due in part to changes in cervical cancer screening recommendations.

CDC/Judy Schmidt; James Gathany

Published in the journal Cancer, the study illustrates some of the challenges in monitoring a vaccine’s impact during a time of concurrent changes in screening. More than half of high-grade cervical lesions that can lead to cancer are caused by persistent HPV infection that can be prevented if a person receives an HPV vaccine. Monitoring trends in the incidence of these lesions is helpful for evaluating the impact of HPV vaccination.

Latest Issues

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026